Bloomberg Vytorin, which combines Zetia with the less-potent agent simvastatin instead of generic Lipitor, is being studied in a closely watched clinical trial to see if it's safe and more effective at preventing heart disease than standard cholesterol-lowering ...
Chicago Tribune Vytorin, which had sales of $1.75 billion in 2012, is currently undergoing a long-term trial to prove that it can reduce heart attacks and strokes better than Zocor ( simvastatin ) alone. While results of that study should definitively determine the ...
Forbes Ezetimibe, marketed as Zetia and, in combination with simvastatin , as Vytorin, was also a blockbuster, though in recent years its popularity has diminished as a result of controversy over the drug's research program and the lack of evidence ...
Doctors Lounge While Zetia does lower "bad" LDL cholesterol linked with heart attacks and strokes, it is no more effective than drugs such as Lipitor, Crestor, or simva...
Forbes Zetia (generically known as ezetimibe) lowers low-density lipoprotein (LDL), the bad cholesterol involved in causing heart attacks and strokes, but less so than existing drugs like Lipitor (generically known as atorvastatin ), Crestor, from AstraZeneca, ...
MarketWatch Sales of ZETIA (ezetimibe) and VYTORIN (ezetimibe/ simvastatin ), medicines for lowering LDL cholesterol, declined 3 percent to $1.0 billion in the first quarter driven by lower sales of VYTORIN, partially offset by growth of ZETIA in the United States ...
dailyRx The most commonly used statin drugs were Lipitor ( atorvastatin ) (63.3 percent) and Zocor (simvastatin) (31.5 percent). Participants also reported taking Mevacor (lovastatin) and Pravachol (pravastatin). Researchers found that the risk of dying from ... and more »
